$ABBV
Abbvie Inc
PRICE
$143.25 βΌ-0.112%
Extented Hours
VOLUME
4,903,432
DAY RANGE
142.2801 - 144.1
52 WEEK
128.24 - 162.75
Join Discuss about ABBV with like-minded investors
@thegiz18 #ivtrades
Good morning, US futures modestly higher across the board /TN still moving upward as 10yr yield drops back below 4% Dollar is flat, while gold and silver are little changed Crude and NG are both trading modestly higher $ETSY looking to add to yesterday's bounce $SOFI adding to yesterday's strength, nearing $9 $RIVN down a bit premarket, looking for more of a pullback $ABBV not moving premarket after $MS reiterates overweight and $180 price target $JPM up near recent highs ahead of Fridays earnings release Trade Well
93 Replies 8 π 6 π₯
Key Metrics
Market Cap
253.20 B
Beta
0
Avg. Volume
5.40 M
Shares Outstanding
1.77 B
Yield
4.07%
Public Float
0
Next Earnings Date
2024-02-08
Next Dividend Date
2024-01-12
Company Information
AbbVie Inc.Β is aΒ pharmaceuticalΒ company headquartered inΒ North Chicago, Illinois. It is ranked 6th on theΒ list of largest biomedical companies by revenue. Their primary product isΒ HumiraΒ (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treatΒ autoimmune diseasesΒ includingΒ rheumatoid arthritis,Β Crohns disease,Β plaque psoriasis, andΒ ulcerative colitis.
CEO: Richard Gonzalez
Website: https://www.abbvie.com/
HQ: 1 N Waukegan Rd North Chicago, 60064-1802 Illinois
Related News